New combo sedation may ease scary lung scopes for kids
NCT ID NCT06755996
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a combination of two sedatives—dexmedetomidine nasal spray and remimazolam—in 150 children aged 2-6 years undergoing bronchoscopy. The goal was to see if this approach provides safe and effective sedation. Researchers measured how quickly children reached adequate sedation and how fast they woke up afterward.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dexmedetomidine and remimazolam
- What this could lead to
- If successful, this sedation approach could make pediatric bronchoscopy safer and more comfortable for children.
- What could go wrong
- This is a small, completed study without a control group, so results may not apply broadly. Risks include allergic reactions or side effects from the drugs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBEROPTIC BRONCHOSCOPY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tongji hospital
Wuhan, Hubei, 430030, China